2007”N‚ÌŠˆ“® |
š‘æ55‰ñ@“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ïš ` 10ŒŽ 21-23“úEŽD–yƒRƒ“ƒxƒ“ƒVƒ‡ƒ“ƒZƒ“ƒ^[CŽD–y ` uHIV-1×–E“àN“ü‚É‚¨‚¯‚éERMƒtƒ@ƒ~ƒŠ[’`”’Ž¿‚ÌŠÖ—^v ‹v•ۉÒ¼C@‹g‹œA˜NC@_ŽR—zC@“c’†—E‰xC ²“¡—T“¿C@ŽR–{’¼Ž÷ uƒGƒ“ƒhƒTƒCƒg[ƒVƒX‘jŠQÜ‚ÌCD4”ñˆË‘¶«HIV-1Š´õ‚ɑ΂·‚é‰e‹¿v ‹g‹œA˜NC@_ŽR—zC@²“¡—T“¿C@ŽR–{’¼Ž÷C@‹v•ۉÒ¼ uHIV-1Š´õ‚É‚¨‚¯‚é–Œ— ‘Å‚¿ƒ^ƒ“ƒpƒNŽ¿‚ÌŠÖ—^GRNAi‚É‚æ‚é–Ô—…“I‰ðÍv _ŽR—zC@‹g‹œA˜NC@²“¡—T“¿C@ŽR–{’¼Ž÷C@‹v•ۉÒ¼ |
2006”N‚ÌŠˆ“® |
š‘æ17”N“x@‘æ1‰ñ‡“¯”ljï‹cš (Œú¶˜J“ȉȊwŒ¤‹†”ï•â•‹àƒGƒCƒY‘ÎôŒ¤‹†Ž–‹Æ) ` 1ŒŽ 24-26“úE‘—§Š´õÇŒ¤‹†ŠCVh ` uHIV-1Š´õ‚É‚¨‚¯‚éERMƒtƒ@ƒ~ƒŠ[’`”’Ž¿‚ÌŠÖ—^v ‹v•ۉÒ¼ |
š‹ž“s‘åŠwƒEƒCƒ‹ƒXŒ¤‹†Š‘n—§50Žü”N‹L”O‘ÛƒVƒ“ƒ|ƒWƒEƒ€E ‘æ‚Q‰ñŒ¤‹†Šƒlƒbƒgƒ[ƒN‘ÛƒVƒ“ƒ|ƒWƒEƒ€@‡“¯ƒVƒ“ƒ|ƒWƒEƒ€ š ` 5ŒŽ 29-31“úE‹ž“s‘åŠwˆãŠw•”ŽÅ—–‰ïŠÙC‹ž“s ` ‹g‹œA˜N |
š‘æ54‰ñ@“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ïš ` 11ŒŽ 19-21“úE–¼ŒÃ‰®‘Û‰ï‹cêC–¼ŒÃ‰® ` uCXCR4“œ½Cü‚É‚æ‚éHIV-1Š´õ–hŒä‚ÆA‚»‚̉ñ”ð‹@\v ‹v•ۉÒ¼C@‰¡ŽR@ŸC@‹g‹œA˜NC@_ŽR—zC@“c’†—E‰xC ²“¡—T“¿C@ŽR–{’¼Ž÷ uHeLa×–E‚É‚¨‚¯‚éCD4”ñˆË‘¶«HIV-1‚Ì×–EN“ü—}§‹@\v ‹g‹œA˜NC@_ŽR—zC@‘åΘa“¿C@“c’†—E‰xC@²“¡—T“¿C ŽR–{’¼Ž÷C@‹v•ۉÒ¼ uƒrƒ^ƒ~ƒ“A—ÞŽ—‘ÌGeranylgeranoic acid (GGA) ‚É‚æ‚éHIV-1Š´õ‚Ì—}§v _ŽR—zC@‹g‹œA˜NC@“c’†—E‰xC@²“¡—T“¿C ŽR–{’¼Ž÷C@Žl“¶ŽqDœAC@‹v•ۉÒ¼ |
2005”N‚ÌŠˆ“® |
š‘æ42‰ñ@“ú–{ƒEƒCƒ‹ƒXŠw‰ï‹ãBŽx•”‘‰ïš ` 7ŒŽ 7-9“úE‰«“ê—«‘‡ƒZƒ“ƒ^[u‚Ä‚¡‚é‚évC“ß”e ` uCXCR4“œ½Cü‚É‚æ‚éCD4”ñˆË‘¶«HIV-1Š´õ‚Ì—}§v ‹v•ۉÒ¼C@‹g‹œA˜NC@“c’†—E‰xC@²“¡—T“¿C@ŽR–{’¼Ž÷ u“¯ŽíŽwŒü«ƒ}ƒEƒXƒŒƒgƒƒEƒCƒ‹ƒX‚ÌhŽåˆæŒˆ’è‹@\‚̉ð–¾v ‹g‹œA˜NC@‘åΘa“¿C@“VÀGC@ŽR–{’¼Ž÷C@‹v•ۉÒ¼ |
š‹¤“¯Œ¤‹†@‹ZpK“¾š ` 9ŒŽ 12-16“úE—‰»ŠwŒ¤‹†ŠE’†‰›Œ¤‹†ŠC˜aŒõ ` uVirus Env - Receptor binding assayv ‹g‹œA˜N |
š‘æ53‰ñ@“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ïš ` 11ŒŽ 20-22“úEƒpƒVƒtƒBƒR‰¡•lC‰¡•l ` uHIV-1‚Ì×–EN“ü‚É‚¨‚¯‚éƒGƒYƒŠƒ“‚ÌŠÖ—^v ‹v•ۉÒ¼C@‹g‹œA˜NC@“c’†—E‰xC@²“¡—T“¿C@ŽR–{’¼Ž÷ uMus dunni ×–EŠ”‚Ì“¯ŽíŽwŒü«ƒ}ƒEƒX”’ŒŒ•aƒEƒCƒ‹ƒX Š´õ’ኴŽó«‚ÌŒˆ’è‹@\v ‹g‹œA˜NC@‘åΘa“¿C@ŽR–{’¼Ž÷C@‹v•ۉÒ¼ |
š‹¤“¯Œ¤‹†‰ïš ` 12ŒŽ 22“úE’·è‘åŠw”M‘шãŠwŒ¤‹†ŠE“–Œ¤‹†ŽºC’·è ` “VÀGæ¶C@‹{ìŒh‚³‚ñC@‹v•ۉÒ¼C ‹g‹œA˜NC@_ŽR—zC@“cŒû³„iˆãŠw•”3”Nj |
2004”N‚ÌŠˆ“® |
šƒŒƒgƒƒEƒCƒ‹ƒXŒ¤‹†‰ï@‰Ä‹GƒZƒ~ƒi[š ` 6ŒŽ4-6“úE¶–½‚ÌXƒŠƒ][ƒg@“ú–{ƒGƒAƒƒrƒNƒXƒZƒ“ƒ^[Cç—t ` uƒŒƒgƒƒEƒCƒ‹ƒX‚ÆhŽå‚Ì‹¤i‰»v ‹v•ۉÒ¼ |
š16th International Workshop on Retroviral Pathogenesisš ` 10ŒŽ 27-31“ú Holiday Inn Midtown Hotel, Montreal, Canada` uDeterminant for the inhibition of ecotropic murine leukemia virus infection by N-linked glycosylation of the rat receptor.v Hiroaki Yoshii, Akinori Ishimoto, Takeshi Ono, Chika Tominaga, Chiho Mitani, Hiroshi Amanuma, Naoki Yamamoto, and Yoshinao Kubo |
š‘æ52‰ñ@“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ïš ` 11ŒŽ 21-23“úEƒpƒVƒtƒBƒR‰¡•lC‰¡•l ` uCD4”ñˆË‘¶«HIV-1Š´õ‚É‚¨‚¯‚郉ƒtƒg‚Ì–ðŠ„v ‹v•ۉÒ¼C@‹g‹œA˜NC@“c’†—E‰xC@²“¡—T“¿C@ŽR–{’¼Ž÷ |